The Small Molecule CMO/CDMO Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Small Molecule CMO/CDMO Market?
The Small Molecule CMO/CDMO Global Market Report 2025 has experienced robust growth in recent years. The market size will increase from $50.58 billion in 2024 to $54.58 billion in 2025, growing at a compound annual growth rate (CAGR) of 7.9%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Small Molecule CMO/CDMO Industry?
By 2029, the Small Molecule CMO/CDMO market is projected to grow to a size of $73.3 billion, with a predicted compound annual growth rate (CAGR) of 7.7%.
Download Your Free Sample of the 2025 Small Molecule CMO/CDMO Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Small Molecule CMO/CDMO Market?
The key drivers in the small molecule cmo/cdmo market are:
• Rise in drug pipelines and the globalization of pharmaceutical operations
• High demand for flexible manufacturing and regulatory compliance expertise
• Biopharmaceutical convergence and sustainable, green manufacturing practices
• Increase in collaborations, partnerships, personalized medicine, and niche therapies.
Global Market Segmentation: Identifying Major Small Molecule CMO/CDMO Industry Segments
The small molecule CMO/CDMO market covered in this report is segmented –
1) By Product: Small Molecule Drug Product, Small Molecule API
2) By Stage Type: Clinical, Commercial, Preclinical
3) By Therapeutic Area: Oncology, Neurology, Infectious Disease, Cardiovascular Disease, Respiratory Disorders, Metabolic Disorders, Other Therapeutics
4) By Application: Cardiovascular, Oncology, Diabetes, Immunological Disorders
Pre-order the 2025 Small Molecule CMO/CDMO Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Small Molecule CMO/CDMO Market?
The key trends in the small molecule cmo/cdmo market are:
• Sustainable and green manufacturing practices are defining emerging trends.
• Increasing collaborations and partnerships are on the rise.
• The move towards personalized medicine and niche therapies is a key trend.
• The integration of digital technologies and rapid response manufacturing are shaping the future of the market.
Who Are the Top Competitors & Leading Players in the Small Molecule CMO/CDMO Market?
Major companies in the small molecule cmo/cdmo market are:
• Patheon NV (Thermo Fisher Scientific)
• GlaxoSmithKline
• Johnson Matthey PLC
• Lonza Group Ltd.
• WuXi AppTec
• Catalent Inc.
• Aurobindo Pharma
• Fareva
• Aesica Pharmaceuticals Limited
• Siegfried holdings AG
• Recipharm AB
• Jubilant Life Sciences Limited
• Almac Group
• Piramal Pharma Solutions
• Oxford Chemicals Inc.
• Syngene International Limited
• Novasep
• Pfizer CentreOne
• GVK Biosciences
• ChemPartner
• Avid Bioservices Inc.
• Dishman Carbogen Amcis Ltd.
• ProChem Inc.
• Metrics Contract Services
Regional Dominance: Which Area Leads the Global Small Molecule CMO/CDMO Market?
North America was the largest region in the small molecule CMO/CDMO market in 2024
